Abstract：Objective To observe the changes of serum 25-hydroxyvitamin D, Interleukin-1β (IL-1β), tumor necrosis factor-α (TNF-α) and urinary albumin creatinine ratio (UACR) in patients with early diabetic nephropathy (DN). Methods A total of 67 patients with early DN who were hospitalized in the Department of Nephrology, the First Affiliated Hospital of Xian Medical University from September to December 2020 were selected as DN group. A total of 74 healthy individuals who underwent physical examination in the First Affiliated Hospital of Xian Medical University during the same period were selected as the control group. The height, body mass index, and blood pressure of each group were collected, and the levels of fasting 25-hydroxyvitamin D, IL-1β and TNF-α, UACR and glucose and lipid metabolism indexes were measured; the relationship between vitamin D and IL-1β, TNF-α, TC, TG, and UACR were analyzed. Results The levels of body mass index, fasting blood glucose and glycosylated hemoglobin in DN group were higher than those in control group, and the differences were statistically significant (P ＜ 0.05). TC, TG, LDL-C and UACR levels in DN group were higher than those in control group, while HDL-C level was lower than control group, the differences were statistically significant (P ＜ 0.05). The level of 25-vitamin D in DN group was lower than that in control group, the difference was statistically significant (P ＜ 0.05). The levels of IL-1β and TNF-α in DN group were higher than those in control group, and the differences were statistically significant (P ＜ 0.05). There was negative correlation between serum 25-hydroxyvitamin D levels and IL-1β, TNF-α level and UACR in DN group (r = -0.647, -0.783, -1.621, P ＜ 0.05). Conclusion The serum 25-hydroxyvitamin D level in patients with early DN is lower than that in normal person, and its level is correlated with inflammatory factors, proteinuria and other risk factors.
兰凯 刘浩昂 刘树义 张旭东 张光伟. 早期糖尿病肾病患者25-羟维生素D及相关指标水平变化[J]. 中国医药导报, 2022, 19(18): 67-70.
LAN Kai LIU Haoang LIU Shuyi ZHANG Xudong ZHANG Guangwei. Changes of 25-hydroxyvitamin D and its related indexes in patients with early diabetic nephropathy. 中国医药导报, 2022, 19(18): 67-70.
[1] 冯松涛，王彬，刘必成.糖尿病肾病新型生物标志物的研究现状和展望[J].中华医学杂志，2021，101（10）：691-694.
[2] 付佳，徐琪，韩睿.维生素D及其受体在糖尿病肾病发病中的研究进展[J].中国医药导报，2020，17（7）：23-26.
[3] 李冬梅，张颖，丁波，等.血清25羟维生素D缺乏与糖尿病肾病的关系[J].中华内科杂志，2013，52（11）：970-974.
[4] Bsem A，Ehac D，Fph A，et al. Air pollution，environmental chemicals，and smoking may trigger vitamin D deficiency：Evidence and potential mechanisms [J]. Environ Int，2019，122： 67-90.
[5] Nam H，Kim HY，Choi JS，et al. Association between Serum 25-hydroxyvitamin D Levels and Type 2 Diabetes in Korean Adults [J]. Chonnam Med J，2017，53（1）：73-77.
[6] 李格菲，毛玉熠，韩睿.维生素D在糖尿病肾病中的肾脏保护作用[J].中国当代医药，2021，28（9）：31-34，61.
[7] 张秀华，曹式丽.糖尿病肾病的发病机制研究进展[J].医学综述，2019，25（6）：1212-1216.
[8] 吴家睿.从糖化血红蛋白控制标准的争论看糖尿病控制：兼论2017年版《中国2型糖尿病防治指南》[J].中华糖尿病杂志，2018，10（5）：318-321.
[9] Kundu R，Theodoraki A，Haas CT，et al. Cell type specific modulation of innate immune signalling by vitamin D in human mononuclear phagocytes [J]. Immunology，2017， 150（1）：55-63.
[10] Corripiomiyar Y，Mellanby RJ，Morrison K，et al. 1，25- Dihydroxyvitamin D3 modulates the phenotype and function of Monocyte derived dendritic cells in cattle [J]. BMC Vet Res，2017，13（1）：390.
[11] 尹乐，王丽妍，刘文虎.维生素D3在糖尿病肾病患者治疗中的作用研究[J].实用药物与临床，2021，24（9）：829-832.
[12] Vanherwegen AS，Gysemans C，Mathieu C. Vitamin D endocrinology on the cross-road between immunity and metabolism [J]. Mol Cell Endocrinol，2017 （453）：52-67.
[13] Fan Y，Yang Q，Yang Y，et al. Sirt6 Suppresses High Glucose-Induced Mitochondrial Dysfunction and Apoptosis in Podocytes through AMPK Activation [J]. Int J Biol Sci，2019，15（3）：701-713.
[14] 兰凯，张光伟，倪菁，等.帕立骨化醇对糖尿病肾病大鼠肾保护作用机制研究[J].西部医学，2017，29（11）：1488-1491.
[15] Jiang W，Wu DB，Xiao GB，et al. An epidemiology survey of vitamin D deficiency and its influencing factors [J]. Med Clín （Barc），2020，154（1）：7-12.
[16] Xue R，Gui D，Zheng L，et al. Mechanistic Insight and Management of Diabetic Nephropathy： Recent Progress and Future Perspective [J]. J Diabetes Res，2017，2017： 1839809.
[17] Hu X，Liu W，Yan Y，et al. Vitamin D protects against diabetic nephropathy： Evidence-based effectiveness and mechanism [J]. Eur J Pharmacol，2019，845：91-98.
[18] Krishnan AV，Feldman D. Mechanisms of the Anti-Cancer and Anti-Inflammatory Actions of Vitamin D [J]. Annu Rev Pharmacol Toxicol，2011，51：311-336.
[19] Liyanage P，Lekamwasam S，Weerarathna TP，et al． Effect of vitamin D therapy on urinary albumin excretion, renal functions, and plasma rennin among patients with diabetic nephrop athy：a randomized ，double-blind clinical trial [J]. J Postgrad Med，2018，64 （1）：10-15.
[20] 赵艾苹，魏剑芬，王建荣，等.糖尿病微血管病变患者血清25-OH维生素D3水平的变化及其影响因素[J].中国医师杂志，2019，21（1）：102-104.
[21] 伍博，谢明.初发2型糖尿病患者血清25-羟维生素D水平及关联性分析[J].中国医药科学，2020，10（22）：193-195.
[22] 王莹，吴东红，程瑶，等.血清胱抑素C与25-羟维生素D及同型半胱氨酸在糖尿病肾病患者中的临床应用价值[J].中国医药，2020，15（11）：1737-1739.
[23] 王英彪，郗光霞.糖尿病肾病患者1，25-二羟基维生素D3与骨钙素水平变化及其相关性分析[J].中国药物与临床，2019，19（11）：1892-1893.
[24] Hamzawy M，Gouda S，Rashid L，et al. The cellular selection between apoptosis and autophagy： roles of vitamin D，glucose and immune response in diabetic nephropathy [J]. Endocrine，2017，58（1）：66-80.
[25] Guo J，Ma Z，Ma Q，et al.1，25（OH）2D3 inhibits hepatocellular carcinoma development through reducing secretion of inflammatory cytokines from immunocytes [J]. Curr Med Chem，2013，20：4131-41.
[26] Guo J，Lu C，Zhang F，et al. VDR Activation Reduces Proteinuria and High-Glucose- Induced Injury of Kidneys and Podocytes by Regulating Wnt Signaling Pathway [J]. Cell Physiol Biochem，2017，43（1）：39-51.
[27] Wang Y，Yang S，Zhou Q，et al. Effects of vitamin D supplementation on renal function，inflammation and glycemic control in patients with diabetic nephropathy：a systematic review and meta-analysis [J]. Kidney Blood Press Res，2019，44：72-87.
京公网安备 11010502046598号